A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria
NCT03095885 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2021-10-28
Summary
Identify individuals with greater absorption of oxalate based on increase in urinary oxalate excretion in response to a controlled oxalate-rich test meal.
Conditions
- Secondary Hyperoxaluria
- Nephrolithiasis
- Hyperoxaluria
- Kidney Stones
Interventions
- OTHER
-
Test Meal
Sponsors & Collaborators
-
Allena Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Annamaria Kausz, MD, MS · Allena Pharmaceuticals
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2017-01-31
- Completion
- 2017-03-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
NCT06892301 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
NCT06989320 ·Status: RECRUITING ·Phase: NA
-
Renal Metabolism of Glycolate to Oxalate
NCT04437225 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
NCT06511349 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Oxalate-Driven Host Responses in Kidney Stone Disease
NCT05417568 ·Status: RECRUITING ·Phase: NA
-
A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria
NCT00490113 ·Status: WITHDRAWN ·Phase: PHASE2
-
Heterozygous Individuals for AGXT and Kidney Stones
NCT04430426 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet
NCT04651088 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Assessment of Endogenous Oxalate Synthesis
NCT05229952 ·Status: COMPLETED ·Phase: NA
-
The Interplay Between Oxalate, Immunity and Infection
NCT04605055 ·Status: WITHDRAWN ·Phase: NA
-
Effectiveness of Urinary Alkalinizing Agents on Kidney Stone Risk
NCT04095975 ·Status: COMPLETED ·Phase: PHASE4
-
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
NCT06330246 ·Status: RECRUITING ·Phase: NA
-
Effect of Weight Loss on Urinary Oxalate Excretion in Obese Calcium Oxalate Kidney Stone Formers
NCT04633811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Obesity and Endogenous Oxalate Synthesis
NCT03808090 ·Status: COMPLETED ·Phase: NA
-
Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease
NCT00395382 ·Status: COMPLETED ·Phase: PHASE4
-
Oxalobacter Formigenes Colonization and Urinary Oxalate Excretion
NCT03752684 ·Status: COMPLETED ·Phase: NA
-
Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria
NCT00280215 ·Status: WITHDRAWN ·Phase: PHASE3
-
Oxalate Formation From Ascorbic Acid
NCT04603898 ·Status: RECRUITING ·Phase: NA
-
Influence of Obesity on Endogenous Oxalate Synthesis
NCT03704350 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hydroxyproline Influence on Oxalate Metabolism
NCT02038543 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism
NCT00800358 ·Status: COMPLETED ·Phase: NA
-
Comparison of DASH With Oxalate Restricted Diet on Urine in Recurrent Stone Formers With Hyperoxaluria
NCT01650935 ·Status: COMPLETED ·Phase: NA
-
Plasma Oxalate in Patient With Short Bowel
NCT04119765 ·Status: COMPLETED
-
Oxazyme in Patients With Hyperoxaluria
NCT01127087 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria
NCT00283387 ·Status: COMPLETED ·Phase: PHASE2